Safety, immunogenicity, persistence and dose evaluation of the CS-2034 mRNA COVID-19 vaccine: a phase II randomized controlled trial in healthy Chinese adults
CS-2034 mRNA COVID-19疫苗的安全性、免疫原性、持久性和剂量评估:一项在中国健康成年人中进行的II期随机对照试验
期刊:BMC Infectious Diseases
影响因子:3
doi:10.1186/s12879-025-12053-4
Jin, Zhili; Wu, Jingxuan; Huang, Tao; Zhao, Kexin; Zhang, Meijuan; Liu, Jun; Song, Jian; Yin, Hang; Wu, Xiaofang; Liu, Jian; Zhu, Tao; Huang, Haitao; Li, Jin; Wang, Haomeng; Gou, Jinbo; Dong, Ruihua